AI-First Product Management
This course is designed to help learners build the product management skills companies are looking for today by blending proven PM practices with the power of AI.
Providence
Dr Andrew Mallon founded Calista Therapeutics in 2012 based upon the discovery and development of a technology platform of therapeutics that modulate the cellular transport, location and activation of regulatory proteins. Dr Mallon is a biotech entrepreneur, specializing in the identification and creation of early stage value in promising therapeutics in diseases that have high unmet clinical need and de-risked development pathways.
Previously Dr Mallon founded Ardane Therapeutics, Inc. (USA), and Carlton Pharmaceutics (UK). Dr Mallon is an inventor on several patents based upon his discoveries in addition to several publications. Dr Mallon has a Ph.D. from the University of Glasgow, taught and undertook research at Brown University and is a registered pharmacist. Dr Mallon has served as an expert scientific reviewer for both the NIH and NSF grant committees focused upon drug development.
This course is designed to help learners build the product management skills companies are looking for today by blending proven PM practices with the power of AI.
This course is designed to prepare learners to use the most powerful Generative AI tools and apply the strategic frameworks needed to leverage them effectively and responsibly.
In this course, the learner will gain a hands-on introduction to data analytics and visualization using SQL and Tableau.
Join our global community of instructors and help shape the next generation of industry leaders — while moving your own career forward with proven subject matter expertise, leadership experience, and public speaking skills. Teach online or on campus, full-time or part-time.
Learn More